Hiroko Inada

1.4k total citations
49 papers, 817 citations indexed

About

Hiroko Inada is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Hiroko Inada has authored 49 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 18 papers in Public Health, Environmental and Occupational Health and 13 papers in Hematology. Recurrent topics in Hiroko Inada's work include Childhood Cancer Survivors' Quality of Life (18 papers), Acute Lymphoblastic Leukemia research (17 papers) and Lymphoma Diagnosis and Treatment (7 papers). Hiroko Inada is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (18 papers), Acute Lymphoblastic Leukemia research (17 papers) and Lymphoma Diagnosis and Treatment (7 papers). Hiroko Inada collaborates with scholars based in Japan, United States and Canada. Hiroko Inada's co-authors include Keizo Horibe, Jun Okamura, Shuichi Ozono, Hideki Izumi, Akira Nakagawara, Yuanyuan Li, Masanori Nishi, Yasushi Ishida, Keiko Asami and Kiyoko Kamibeppu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Pediatrics.

In The Last Decade

Hiroko Inada

49 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroko Inada Japan	17	321	236	171	156	145	49	817
Archie Bleyer United States	11	338 1.1×	400 1.7×	92 0.5×	150 1.0×	71 0.5×	22	883
Lucie M. Turcotte United States	16	386 1.2×	280 1.2×	102 0.6×	145 0.9×	54 0.4×	79	911
Claire Berger France	21	534 1.7×	441 1.9×	165 1.0×	190 1.2×	132 0.9×	84	1.3k
Leslie Robison United States	7	357 1.1×	292 1.2×	138 0.8×	56 0.4×	49 0.3×	8	701
Maurizio Mascarin Italy	18	260 0.8×	154 0.7×	98 0.6×	202 1.3×	115 0.8×	86	1.0k
Keiko Asami Japan	18	376 1.2×	314 1.3×	86 0.5×	259 1.7×	152 1.0×	53	943
Mark E. Weinblatt United States	16	238 0.7×	118 0.5×	86 0.5×	111 0.7×	152 1.0×	47	1.0k
S. Sauter Germany	13	460 1.4×	691 2.9×	136 0.8×	108 0.7×	69 0.5×	20	1.1k
Isaac Odame Canada	21	372 1.2×	214 0.9×	167 1.0×	259 1.7×	25 0.2×	49	1.2k
Katarzyna Derwich Poland	12	193 0.6×	226 1.0×	43 0.3×	86 0.6×	62 0.4×	70	550

Countries citing papers authored by Hiroko Inada

Since Specialization

Citations

This map shows the geographic impact of Hiroko Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Inada more than expected).

Fields of papers citing papers by Hiroko Inada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Inada. The network helps show where Hiroko Inada may publish in the future.

Co-authorship network of co-authors of Hiroko Inada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Inada. A scholar is included among the top collaborators of Hiroko Inada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Inada. Hiroko Inada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Masahiro, Akiko Izawa, Atsushi Shibata, et al.. (2019). Cellular Uptake of a Novel siRNA-Based Oligonucleotide, TRK-250 in Lung Cells. A5242–A5242. 1 indexed citations

Ishida, Yasushi, Miho Maeda, Souichi Adachi, et al.. (2018). Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer. International Journal of Clinical Oncology. 23(6). 1178–1188. 10 indexed citations

Yamamoto, Toshiyuki, Taiju Utsugisawa, Takako Aoki, et al.. (2016). The Novel Missense Mutation of GATA1 Caused Red Cell Adenosine Deaminase Overproduction Associated with Congenital Hemolytic Anemia. Blood. 128(22). 400–400. 1 indexed citations

Ozono, Shuichi, Maiko Noguchi, Shinichiro Nakagawa, et al.. (2016). Critical Diamond–Blackfan anemia due to ribosomal protein S19 missense mutation. Pediatrics International. 58(9). 930–933. 2 indexed citations

Sekimizu, Masahiro, Tetsuya Mori, Akira Kikuchi, et al.. (2015). Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG). Pediatric Blood & Cancer. 62(7). 1294–1296. 5 indexed citations

Ishida, Yasushi, Dongmei Qiu, Miho Maeda, et al.. (2015). Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan. International Journal of Clinical Oncology. 21(3). 506–516. 15 indexed citations

Tsurusawa, Masahito, Masahiko Gosho, Tetsuya Mori, et al.. (2014). Statistical analysis of relation between plasma methotrexate concentration and toxicity in high‐dose methotrexate therapy of childhood nonHodgkin lymphoma. Pediatric Blood & Cancer. 62(2). 279–284. 35 indexed citations

Nishimura, Shotaro, Hiroko Inada, Yoshihiko Sawa, & Hiroyuki Ishikawa. (2013). Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers. European Journal of Cancer Care. 22(3). 353–360. 21 indexed citations

Povalko, Nataliya, Yoshihisa Nagatoshi, Hiroko Inada, Shuichi Yatsuga, & Yasutoshi Koga. (2012). A novel sequence variant of tRNAThr in mtDNA, transferred by bone marrow transplantation in patient with ALL. Mitochondrion. 12(5). 551–551. 1 indexed citations

10.

Kinoshita, Yoshiaki, Aiko Suminoe, Hiroko Inada, et al.. (2012). The prognostic significance of blastemal predominant histology in initially resected Wilms’ tumors: A report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan. Journal of Pediatric Surgery. 47(12). 2205–2209. 16 indexed citations

11.

Koga, Yuhki, Masaaki Kumagai, Tetsuya Takimoto, et al.. (2012). [Retrospective analysis of 157 patients with pediatric Hodgkin lymphoma in Japan: investigation by four pediatric cancer study groups].. PubMed. 53(4). 443–9. 4 indexed citations

12.

Ozono, Shuichi, Hiroko Inada, Shinichiro Nakagawa, et al.. (2011). Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells. International Journal of Hematology. 93(3). 389–393. 22 indexed citations

13.

Ishida, Yasushi, Naoko Sakamoto, Kiyoko Kamibeppu, et al.. (2010). Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy. International Journal of Hematology. 92(1). 95–104. 36 indexed citations

14.

Fujita, Naoto, Tetsuya Mori, Tetsuo Mitsui, et al.. (2008). The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B‐cell non‐Hodgkin lymphoma and mature B‐cell leukemia: A retrospective analysis of enrolled cases in Japan. Pediatric Blood & Cancer. 51(2). 188–192. 24 indexed citations

15.

Suita, Sachiyo, Yoshiaki Kinoshita, Tatsuro Tajiri, et al.. (2006). Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. Journal of Pediatric Surgery. 41(9). 1501–1505. 8 indexed citations

16.

Matsuzaki, Akinobu, Yoshihisa Nagatoshi, Hiroko Inada, et al.. (2005). Prognostic factors for relapsed childhood acute lymphoblastic leukemia: Impact of allogeneic stem cell transplantation—a report from the Kyushu-Yamaguchi Children's Cancer Study Group. Pediatric Blood & Cancer. 45(2). 111–120. 8 indexed citations

17.

Ohara, Akira, Seiji Kojima, Jun Okamura, et al.. (2002). Evolution of myelodysplastic syndrome and acute  myelogenous leukaemia in children with hepatitis‐associated  aplastic anaemia. British Journal of Haematology. 116(1). 151–154. 16 indexed citations

18.

Shimizu, Takashi, Ichiro Yoshida, Haruhiko Eguchi, et al.. (1996). Sweet Syndrome in a Child with Aplastic Anemia Receiving Recombinant Granulocyte Colony-Stimulating Factor. Journal of Pediatric Hematology/Oncology. 18(3). 282–284. 33 indexed citations

19.

Sugita, Yasuo, Takashi Yamamoto, Kazuya Morimoto, et al.. (1994). Neuroblastomas of the Central Nervous System. Clinicopathological Features of a Cerebellar Neuroblastoma in Comparison with a Metastatic Cerebral Neuroblastoma.. The Kurume Medical Journal. 41(2). 87–95. 1 indexed citations

20.

Aoki, Megumi, Tetsuya Ohtaki, Takayuki Seki, et al.. (1992). A FIFTY TWO-WEEK ORAL REPEATED DOSE TOXICITY STUDY OF SUPLATAST TOSILATE (IPD-1151T) IN DOGS. The Journal of Toxicological Sciences. 17(SupplementII). 101–139. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact